Ruth Plummer
Newcastle upon Tyne Hospitals NHS Foundation Trust(GB)Freeman Hospital(GB)Morristown Medical Center(US)Sir Bobby Robson Foundation(GB)Clinical Research Institute(US)Newcastle upon Tyne Hospital(GB)University of Newcastle Australia(AU)Newcastle University(GB)
Publications by Year
Research Areas
PARP inhibition in cancer therapy, DNA Repair Mechanisms, Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Adjuvant Dabrafenib plus Trametinib in Stage IIIBRAF-Mutated Melanoma(2017)1,459 cited
- → Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial(2015)423 cited
- → Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma(2020)400 cited
- → Phase I Study of the Poly(ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors(2008)381 cited
- → A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours(2011)379 cited
- → Mechanisms of Chemoresistance to Alkylating Agents in Malignant Glioma(2008)367 cited